News from us and our partners

Tags

Topics

0 results

News
14 February, 2024
NodThera publishes preclinical data on NLRP3 inhibitors in obesity
News
13 February, 2024
deepc acquires Osimis platform: strengthening the AI infrastructure for radiology at scale
News
12 February, 2024
Mainstay Medical announces receipt of FDA approval for MRI labeling on ReActiv8® Restorative Neurostimulation System
News
9 February, 2024
Sensorion raises €50.5M with US and European investors
News
7 February, 2024
Artios Pharma appoints Christine Silverstein as CFO
News
7 February, 2024
Jazz Pharmaceuticals enters definitive agreement with Redx Pharma to acquire global rights to KRAS Inhibitor Program
News
6 February, 2024
Sofinnova publishes 2023 Impact Report
Feature
6 February, 2024
2023 Impact Report: A hands-on investment strategy driving positive change for the planet
News
31 January, 2024
AAVantgarde appoints Nina (Ekaterini) Kotsopoulou, PhD, as Chief Technical Officer
News
30 January, 2024
BrightHeart welcomes Michael Butchko as an independent board member
News
23 January, 2024
Enthera Pharmaceuticals appoints Lisa M. Olson as CEO and announces clinical trial progress with Ent001
News
22 January, 2024
Pi-Cardia receives FDA Breakthrough Device Designation for ShortCut™
News
19 January, 2024
Sensorion receives approval to start Phase 1/2 trial
News
16 January, 2024
DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing
News
10 January, 2024
Qorium lands additional funds from Brightlands Venture Partners and Sofinnova Partners, as the company sets out on an ambitious growth drive for sustainable leather with the appointment of CEO Michael Newton
News
10 January, 2024
Inventiva draws down €25M second tranche from EIB

NodThera publishes preclinical data on NLRP3 inhibitors in obesity

deepc acquires Osimis platform: strengthening the AI infrastructure for radiology at scale

Mainstay Medical announces receipt of FDA approval for MRI labeling on ReActiv8® Restorative Neurostimulation System

Sensorion raises €50.5M with US and European investors

Artios Pharma appoints Christine Silverstein as CFO

Jazz Pharmaceuticals enters definitive agreement with Redx Pharma to acquire global rights to KRAS Inhibitor Program

Sofinnova publishes 2023 Impact Report

2023 Impact Report: A hands-on investment strategy driving positive change for the planet

AAVantgarde appoints Nina (Ekaterini) Kotsopoulou, PhD, as Chief Technical Officer

BrightHeart welcomes Michael Butchko as an independent board member

Enthera Pharmaceuticals appoints Lisa M. Olson as CEO and announces clinical trial progress with Ent001

Pi-Cardia receives FDA Breakthrough Device Designation for ShortCut™

Sensorion receives approval to start Phase 1/2 trial

DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing

Qorium lands additional funds from Brightlands Venture Partners and Sofinnova Partners, as the company sets out on an ambitious growth drive for sustainable leather with the appointment of CEO Michael Newton

Inventiva draws down €25M second tranche from EIB